Gupta A, Pahal S, Kumar V, Chaudhary A (2025) Role of monoclonal antibodies in Alzheimers disease: successes, failures, and future directions
Although a prior cohort study did not show a statistically significant reduction in major cardiovascular events among patients with no previous history of cardiovascular disease [148], a meta-analysis of eight clinical trials evaluating the effect of GLP-1R agonists on cardiovascular outcomes reported a 14% reduction in major adverse cardiovascular events, with no significant heterogeneity across GLP-1R agonists or subgroups, including patients with or without previous cardiovascular disease [149]
3a, Online Resource 3)
Moreover, a down-regulation of p-NFB p65 was also demonstrated in those studies (18, 19)
What Is Sermorelin and How Does It Work
That said, it's still likely to be responsible for some symptoms, if not all, so topping up your water levels can only help